Nair et al. found that the abundance of the major antibody classes measured in sera from patients with acute to late-stage Lyme disease progressed in sequence as might be predicted for development of an antibody B cell response (i.e., IgM→ IgG→ IgA). Here, CD79A is linked to Lyme disease.